Literature DB >> 19874825

Pancreatic cancer cells activate CCL5 expression in mesenchymal stromal cells through the insulin-like growth factor-I pathway.

Hideki Makinoshima1, Mari Dezawa.   

Abstract

Mesenchymal stromal cells (MSCs) have a critical role in cancer progression and metastasis. Despite extensive studies of the physiological responses in cancer cells, the molecular mechanisms regulating gene expression in MSCs by cancer cells remain undefined. Here we demonstrate that CC chemokine ligand 5 (CCL5) expression was increased in MSCs co-cultured with pancreatic cancer cells (PCCs), and this activation was dependent on extracellular insulin-like growth factor (IGF-I). Moreover, CCL5 induction in MSCs was required for the activation of IGF-I pathway in PCCs. These results reveal a link between the IGF-I pathway in PCCs and CCL5 pathway in MSCs through the interaction of those cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19874825     DOI: 10.1016/j.febslet.2009.10.061

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

Review 1.  Influence of Dipeptidyl Peptidase-4 (DPP4) on Mesenchymal Stem-Cell (MSC) Biology: Implications for Regenerative Medicine - Review.

Authors:  Bárbara Torrecillas-Baena; María Ángeles Gálvez-Moreno; José Manuel Quesada-Gómez; Gabriel Dorado; Antonio Casado-Díaz
Journal:  Stem Cell Rev Rep       Date:  2021-10-22       Impact factor: 5.739

2.  CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells.

Authors:  Santosh Kumar Singh; Manoj K Mishra; Isam-Eldin A Eltoum; Sejong Bae; James W Lillard; Rajesh Singh
Journal:  Sci Rep       Date:  2018-01-22       Impact factor: 4.996

Review 3.  Mesenchymal stem cells and cancer therapy: insights into targeting the tumour vasculature.

Authors:  Surendar Aravindhan; Sura Salman Ejam; Methaq Hadi Lafta; Alexander Markov; Alexei Valerievich Yumashev; Majid Ahmadi
Journal:  Cancer Cell Int       Date:  2021-03-08       Impact factor: 5.722

Review 4.  CCL5/CCR5 axis in human diseases and related treatments.

Authors:  Zhen Zeng; Tianxia Lan; Yuquan Wei; Xiawei Wei
Journal:  Genes Dis       Date:  2021-08-26

5.  Adipocyte-released insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in vitro.

Authors:  V D'Esposito; F Passaretti; A Hammarstedt; D Liguoro; D Terracciano; G Molea; L Canta; C Miele; U Smith; F Beguinot; P Formisano
Journal:  Diabetologia       Date:  2012-07-15       Impact factor: 10.122

6.  PTPRZ1 regulates calmodulin phosphorylation and tumor progression in small-cell lung carcinoma.

Authors:  Hideki Makinoshima; Genichiro Ishii; Motohiro Kojima; Satoshi Fujii; Youichi Higuchi; Takeshi Kuwata; Atsushi Ochiai
Journal:  BMC Cancer       Date:  2012-11-21       Impact factor: 4.430

7.  IL-1β produced by aggressive breast cancer cells is one of the factors that dictate their interactions with mesenchymal stem cells through chemokine production.

Authors:  Pauline Escobar; Céline Bouclier; Julien Serret; Ivan Bièche; Madly Brigitte; Andres Caicedo; Elodie Sanchez; Sophie Vacher; Marie-Luce Vignais; Philippe Bourin; David Geneviève; Franck Molina; Christian Jorgensen; Gwendal Lazennec
Journal:  Oncotarget       Date:  2015-10-06

Review 8.  Insulin/IGF-driven cancer cell-stroma crosstalk as a novel therapeutic target in pancreatic cancer.

Authors:  Ayse Ceren Mutgan; H Erdinc Besikcioglu; Shenghan Wang; Helmut Friess; Güralp O Ceyhan; Ihsan Ekin Demir
Journal:  Mol Cancer       Date:  2018-02-23       Impact factor: 27.401

Review 9.  Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance.

Authors:  Priscilla Cascetta; Alessandro Cavaliere; Geny Piro; Lorena Torroni; Raffaela Santoro; Giampaolo Tortora; Davide Melisi; Carmine Carbone
Journal:  Int J Mol Sci       Date:  2018-10-25       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.